Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Polymorphism, Single Nucleotide | 81 | 2024 | 16039 | 2.340 |
Why?
|
Stomach Neoplasms | 25 | 2022 | 1469 | 2.270 |
Why?
|
Colorectal Neoplasms | 42 | 2024 | 6958 | 1.810 |
Why?
|
Urinary Bladder Neoplasms | 21 | 2024 | 2176 | 1.700 |
Why?
|
MicroRNAs | 19 | 2023 | 3788 | 1.330 |
Why?
|
Genetic Predisposition to Disease | 58 | 2024 | 18074 | 1.190 |
Why?
|
Genome-Wide Association Study | 37 | 2024 | 12803 | 0.950 |
Why?
|
Case-Control Studies | 52 | 2024 | 22228 | 0.700 |
Why?
|
China | 21 | 2024 | 2383 | 0.680 |
Why?
|
Peptidyl-Dipeptidase A | 2 | 2022 | 323 | 0.650 |
Why?
|
Body Fluids | 1 | 2021 | 320 | 0.630 |
Why?
|
DNA, Mitochondrial | 1 | 2024 | 869 | 0.620 |
Why?
|
Gene Expression Regulation, Neoplastic | 22 | 2024 | 8603 | 0.590 |
Why?
|
Adenosine | 5 | 2024 | 813 | 0.570 |
Why?
|
Quantitative Trait Loci | 13 | 2024 | 2136 | 0.560 |
Why?
|
Lung Neoplasms | 12 | 2024 | 13446 | 0.530 |
Why?
|
Genotype | 30 | 2024 | 13026 | 0.470 |
Why?
|
Genetic Association Studies | 10 | 2021 | 2744 | 0.450 |
Why?
|
Promoter Regions, Genetic | 12 | 2020 | 5784 | 0.430 |
Why?
|
Carcinogens | 3 | 2024 | 451 | 0.430 |
Why?
|
Particulate Matter | 10 | 2023 | 2623 | 0.420 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 7 | 2024 | 5379 | 0.410 |
Why?
|
Prognosis | 34 | 2024 | 29890 | 0.390 |
Why?
|
Mendelian Randomization Analysis | 6 | 2023 | 1038 | 0.390 |
Why?
|
Genetic Variation | 11 | 2021 | 6612 | 0.390 |
Why?
|
Genomics | 4 | 2024 | 5925 | 0.380 |
Why?
|
RNA, Small Interfering | 4 | 2024 | 3419 | 0.370 |
Why?
|
Gastrointestinal Diseases | 1 | 2020 | 1204 | 0.370 |
Why?
|
Humans | 155 | 2024 | 765926 | 0.360 |
Why?
|
Alleles | 15 | 2024 | 6891 | 0.350 |
Why?
|
Homeodomain Proteins | 2 | 2015 | 2430 | 0.320 |
Why?
|
Carcinoma, Papillary | 1 | 2014 | 786 | 0.310 |
Why?
|
Male | 90 | 2024 | 363815 | 0.300 |
Why?
|
Colonic Neoplasms | 4 | 2024 | 2530 | 0.300 |
Why?
|
Nephrolithiasis | 2 | 2022 | 117 | 0.290 |
Why?
|
DNA Methylation | 7 | 2021 | 4424 | 0.290 |
Why?
|
Methyltransferases | 4 | 2023 | 372 | 0.290 |
Why?
|
Prostatic Neoplasms | 4 | 2024 | 11090 | 0.280 |
Why?
|
ROC Curve | 8 | 2021 | 3612 | 0.280 |
Why?
|
Middle Aged | 64 | 2024 | 223016 | 0.280 |
Why?
|
Female | 89 | 2024 | 396141 | 0.270 |
Why?
|
Carcinoma, Renal Cell | 3 | 2020 | 3183 | 0.270 |
Why?
|
Autophagy | 3 | 2024 | 1350 | 0.270 |
Why?
|
Area Under Curve | 5 | 2021 | 1637 | 0.270 |
Why?
|
CpG Islands | 3 | 2020 | 1207 | 0.270 |
Why?
|
DNA Damage | 4 | 2020 | 2462 | 0.260 |
Why?
|
Organic Cation Transport Proteins | 2 | 2019 | 61 | 0.260 |
Why?
|
Neoplasms | 8 | 2024 | 22340 | 0.260 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3940 | 0.250 |
Why?
|
Exosomes | 2 | 2022 | 417 | 0.250 |
Why?
|
Risk Factors | 31 | 2024 | 74850 | 0.250 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2024 | 1559 | 0.250 |
Why?
|
Kidney Neoplasms | 3 | 2020 | 4278 | 0.240 |
Why?
|
Cell Proliferation | 9 | 2022 | 10426 | 0.240 |
Why?
|
Endonucleases | 2 | 2020 | 372 | 0.240 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2024 | 43 | 0.230 |
Why?
|
Receptors, Serotonin, 5-HT3 | 1 | 2024 | 45 | 0.230 |
Why?
|
Glucuronosyltransferase | 2 | 2024 | 136 | 0.230 |
Why?
|
Aged | 48 | 2024 | 171163 | 0.230 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 2 | 2022 | 58 | 0.230 |
Why?
|
Environmental Pollutants | 2 | 2024 | 1294 | 0.230 |
Why?
|
Air Pollution | 3 | 2024 | 2380 | 0.220 |
Why?
|
Survival Analysis | 13 | 2021 | 10086 | 0.220 |
Why?
|
Tumor Suppressor Proteins | 3 | 2020 | 2795 | 0.210 |
Why?
|
Cell Line, Tumor | 13 | 2024 | 17060 | 0.210 |
Why?
|
Environmental Exposure | 7 | 2024 | 4544 | 0.210 |
Why?
|
Air Pollutants | 4 | 2024 | 2922 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3109 | 0.200 |
Why?
|
Transcription Factors | 5 | 2024 | 12129 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3231 | 0.200 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2024 | 423 | 0.190 |
Why?
|
3' Untranslated Regions | 4 | 2018 | 514 | 0.190 |
Why?
|
Databases, Genetic | 4 | 2021 | 1756 | 0.190 |
Why?
|
Peroxisomes | 1 | 2022 | 63 | 0.190 |
Why?
|
Smoking | 6 | 2024 | 9082 | 0.190 |
Why?
|
Neoplasm Staging | 10 | 2020 | 11196 | 0.190 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2022 | 116 | 0.190 |
Why?
|
Gene Expression Profiling | 8 | 2024 | 9525 | 0.180 |
Why?
|
Nomograms | 2 | 2020 | 235 | 0.180 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 1 | 2021 | 85 | 0.180 |
Why?
|
DNA Primase | 1 | 2021 | 110 | 0.180 |
Why?
|
Cardia | 1 | 2020 | 61 | 0.170 |
Why?
|
Gene Frequency | 8 | 2021 | 3623 | 0.170 |
Why?
|
Nutrition Surveys | 2 | 2024 | 1735 | 0.170 |
Why?
|
Early Detection of Cancer | 3 | 2024 | 3238 | 0.170 |
Why?
|
Sialoglycoproteins | 1 | 2021 | 313 | 0.170 |
Why?
|
Secretory Pathway | 1 | 2020 | 53 | 0.170 |
Why?
|
Gastric Acid | 1 | 2020 | 98 | 0.170 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2021 | 237 | 0.170 |
Why?
|
Biosynthetic Pathways | 1 | 2020 | 138 | 0.170 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2020 | 89 | 0.170 |
Why?
|
Light Coagulation | 1 | 2019 | 72 | 0.170 |
Why?
|
Signal Transduction | 11 | 2021 | 23597 | 0.170 |
Why?
|
Glaucoma, Neovascular | 1 | 2019 | 37 | 0.160 |
Why?
|
Sequence Analysis, RNA | 2 | 2017 | 2036 | 0.160 |
Why?
|
5-Methylcytosine | 1 | 2020 | 146 | 0.160 |
Why?
|
Laminin | 1 | 2021 | 404 | 0.160 |
Why?
|
Pseudogenes | 1 | 2019 | 104 | 0.160 |
Why?
|
Choline | 2 | 2022 | 511 | 0.160 |
Why?
|
Replication Protein A | 1 | 2019 | 54 | 0.160 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2024 | 750 | 0.160 |
Why?
|
Cation Transport Proteins | 1 | 2021 | 325 | 0.160 |
Why?
|
Proportional Hazards Models | 9 | 2024 | 12529 | 0.150 |
Why?
|
Phosphoinositide Phospholipase C | 1 | 2018 | 28 | 0.150 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 330 | 0.150 |
Why?
|
MAP Kinase Signaling System | 2 | 2024 | 1489 | 0.150 |
Why?
|
Xanthine Dehydrogenase | 1 | 2018 | 18 | 0.150 |
Why?
|
Glucosylceramidase | 1 | 2019 | 124 | 0.150 |
Why?
|
Glaucoma Drainage Implants | 1 | 2019 | 107 | 0.150 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2018 | 50 | 0.150 |
Why?
|
Life Style | 3 | 2024 | 3928 | 0.150 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2021 | 352 | 0.150 |
Why?
|
Catalase | 1 | 2018 | 214 | 0.150 |
Why?
|
RNA, Neoplasm | 1 | 2021 | 745 | 0.150 |
Why?
|
Kidney Calculi | 1 | 2022 | 458 | 0.150 |
Why?
|
Lectins, C-Type | 1 | 2021 | 592 | 0.150 |
Why?
|
Platinum Compounds | 1 | 2018 | 94 | 0.150 |
Why?
|
Superoxide Dismutase | 1 | 2020 | 593 | 0.150 |
Why?
|
Survival Rate | 8 | 2024 | 12822 | 0.150 |
Why?
|
Riboflavin | 1 | 2018 | 107 | 0.150 |
Why?
|
Sulfotransferases | 1 | 2018 | 151 | 0.140 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2018 | 111 | 0.140 |
Why?
|
Glutathione Peroxidase | 1 | 2018 | 257 | 0.140 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2017 | 21 | 0.140 |
Why?
|
Down-Regulation | 3 | 2020 | 2925 | 0.140 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2017 | 120 | 0.140 |
Why?
|
Betaine | 1 | 2016 | 90 | 0.130 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2022 | 492 | 0.130 |
Why?
|
Computational Biology | 5 | 2021 | 3562 | 0.130 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2019 | 370 | 0.130 |
Why?
|
Helicobacter Infections | 1 | 2020 | 390 | 0.130 |
Why?
|
Cyclophilins | 1 | 2016 | 47 | 0.130 |
Why?
|
Phenotype | 6 | 2020 | 16714 | 0.130 |
Why?
|
Nutritional Status | 1 | 2024 | 1620 | 0.130 |
Why?
|
Circadian Clocks | 1 | 2018 | 169 | 0.130 |
Why?
|
Algorithms | 5 | 2021 | 14064 | 0.130 |
Why?
|
RNA-Binding Proteins | 2 | 2024 | 1882 | 0.130 |
Why?
|
Vitamin B Complex | 1 | 2018 | 299 | 0.130 |
Why?
|
Risk | 9 | 2018 | 9599 | 0.130 |
Why?
|
Gonadal Steroid Hormones | 1 | 2020 | 706 | 0.130 |
Why?
|
Estrogens | 2 | 2024 | 1528 | 0.130 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2016 | 4563 | 0.130 |
Why?
|
RNA, Messenger | 9 | 2022 | 12768 | 0.130 |
Why?
|
DNA Glycosylases | 1 | 2016 | 125 | 0.130 |
Why?
|
Head and Neck Neoplasms | 2 | 2022 | 2924 | 0.120 |
Why?
|
Tea | 1 | 2017 | 289 | 0.120 |
Why?
|
Dietary Supplements | 3 | 2018 | 3427 | 0.120 |
Why?
|
Metabolic Networks and Pathways | 1 | 2020 | 797 | 0.120 |
Why?
|
Single-Cell Analysis | 3 | 2024 | 2536 | 0.120 |
Why?
|
Mucin-1 | 1 | 2020 | 535 | 0.120 |
Why?
|
Cell Adhesion Molecules | 1 | 2021 | 1609 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2016 | 313 | 0.120 |
Why?
|
Digestive System Neoplasms | 1 | 2015 | 82 | 0.120 |
Why?
|
Prosthesis Implantation | 1 | 2019 | 594 | 0.120 |
Why?
|
Nephrectomy | 1 | 2020 | 927 | 0.120 |
Why?
|
Blood Cells | 1 | 2017 | 307 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1996 | 0.120 |
Why?
|
Binding Sites | 3 | 2018 | 5999 | 0.120 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2016 | 386 | 0.120 |
Why?
|
Prospective Studies | 8 | 2024 | 54807 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 6 | 2021 | 6503 | 0.120 |
Why?
|
Consensus | 1 | 2024 | 3202 | 0.120 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2022 | 4044 | 0.110 |
Why?
|
Follow-Up Studies | 10 | 2020 | 39228 | 0.110 |
Why?
|
Risk Assessment | 9 | 2024 | 24275 | 0.110 |
Why?
|
Quantitative Trait, Heritable | 1 | 2017 | 541 | 0.110 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2022 | 958 | 0.110 |
Why?
|
Epigenomics | 1 | 2020 | 958 | 0.110 |
Why?
|
Cohort Studies | 8 | 2024 | 41680 | 0.110 |
Why?
|
Oxidoreductases | 1 | 2016 | 409 | 0.110 |
Why?
|
Adenocarcinoma | 3 | 2017 | 6360 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2019 | 2945 | 0.110 |
Why?
|
Asthma | 2 | 2023 | 6268 | 0.110 |
Why?
|
Linkage Disequilibrium | 3 | 2024 | 1996 | 0.110 |
Why?
|
Anticarcinogenic Agents | 1 | 2015 | 250 | 0.110 |
Why?
|
Caspase 8 | 1 | 2014 | 198 | 0.110 |
Why?
|
Gastric Mucosa | 1 | 2016 | 602 | 0.110 |
Why?
|
Fas Ligand Protein | 1 | 2014 | 214 | 0.110 |
Why?
|
Fluorouracil | 1 | 2018 | 1648 | 0.110 |
Why?
|
Bayes Theorem | 2 | 2022 | 2353 | 0.110 |
Why?
|
Feces | 1 | 2020 | 1503 | 0.110 |
Why?
|
Up-Regulation | 2 | 2021 | 4130 | 0.100 |
Why?
|
Endometrial Neoplasms | 1 | 2022 | 1378 | 0.100 |
Why?
|
RNA Splicing | 1 | 2017 | 902 | 0.100 |
Why?
|
Urinary Bladder | 2 | 2020 | 1155 | 0.100 |
Why?
|
Fatty Acids | 1 | 2020 | 1804 | 0.100 |
Why?
|
Urologic Neoplasms | 1 | 2016 | 312 | 0.100 |
Why?
|
Protein Isoforms | 1 | 2017 | 1716 | 0.100 |
Why?
|
Proteomics | 3 | 2022 | 3906 | 0.100 |
Why?
|
Adult | 21 | 2024 | 223088 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2024 | 2040 | 0.100 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2814 | 0.100 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 384 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 360 | 0.100 |
Why?
|
Epigenesis, Genetic | 3 | 2020 | 3816 | 0.100 |
Why?
|
Ribonuclease III | 1 | 2013 | 271 | 0.100 |
Why?
|
Sequence Analysis, DNA | 2 | 2020 | 4780 | 0.100 |
Why?
|
BRCA2 Protein | 1 | 2016 | 802 | 0.090 |
Why?
|
Lymphatic Metastasis | 2 | 2018 | 2885 | 0.090 |
Why?
|
Odds Ratio | 6 | 2020 | 9656 | 0.090 |
Why?
|
Tandem Mass Spectrometry | 3 | 2024 | 1194 | 0.090 |
Why?
|
Aged, 80 and over | 9 | 2020 | 59496 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3431 | 0.090 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 852 | 0.090 |
Why?
|
Dendritic Cells | 1 | 2021 | 2745 | 0.090 |
Why?
|
Adenosine Triphosphatases | 1 | 2014 | 839 | 0.080 |
Why?
|
Mutation | 4 | 2024 | 30192 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2014 | 1186 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 12235 | 0.080 |
Why?
|
Methylation | 2 | 2024 | 1074 | 0.080 |
Why?
|
Nuclear Proteins | 3 | 2024 | 5782 | 0.080 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2014 | 723 | 0.080 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1748 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2020 | 3048 | 0.080 |
Why?
|
Likelihood Functions | 2 | 2022 | 993 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2018 | 2877 | 0.080 |
Why?
|
Animals | 16 | 2024 | 168735 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3661 | 0.080 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11895 | 0.080 |
Why?
|
Peptide Fragments | 1 | 2021 | 5126 | 0.080 |
Why?
|
Folic Acid | 1 | 2015 | 1337 | 0.080 |
Why?
|
Mice | 11 | 2024 | 81782 | 0.080 |
Why?
|
Genome, Human | 2 | 2019 | 4443 | 0.070 |
Why?
|
Cisplatin | 1 | 2014 | 1654 | 0.070 |
Why?
|
Models, Biological | 2 | 2021 | 9443 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2020 | 15802 | 0.070 |
Why?
|
Vitamin E | 2 | 2022 | 872 | 0.070 |
Why?
|
Overweight | 1 | 2018 | 2444 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2023 | 3419 | 0.070 |
Why?
|
HCT116 Cells | 2 | 2018 | 399 | 0.070 |
Why?
|
Body Mass Index | 2 | 2021 | 13042 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6058 | 0.060 |
Why?
|
Exons | 2 | 2023 | 2393 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2016 | 2969 | 0.060 |
Why?
|
Colonoscopy | 2 | 2024 | 1408 | 0.060 |
Why?
|
Comet Assay | 2 | 2015 | 74 | 0.060 |
Why?
|
2',5'-Oligoadenylate Synthetase | 1 | 2024 | 27 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10843 | 0.060 |
Why?
|
Apoptosis | 3 | 2019 | 9505 | 0.060 |
Why?
|
Neoplasm Invasiveness | 3 | 2020 | 3599 | 0.060 |
Why?
|
Multifactorial Inheritance | 2 | 2023 | 1426 | 0.060 |
Why?
|
Histones | 1 | 2015 | 2590 | 0.060 |
Why?
|
Hydroxysteroid Dehydrogenases | 1 | 2024 | 30 | 0.060 |
Why?
|
Benzo(a)pyrene | 1 | 2024 | 26 | 0.060 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4249 | 0.060 |
Why?
|
Glucose Transporter Type 5 | 1 | 2023 | 13 | 0.060 |
Why?
|
Nitrosamines | 1 | 2024 | 85 | 0.060 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2024 | 101 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5333 | 0.060 |
Why?
|
RNA | 2 | 2024 | 2716 | 0.050 |
Why?
|
Qc-SNARE Proteins | 1 | 2023 | 21 | 0.050 |
Why?
|
Neoplasm Transplantation | 2 | 2018 | 2008 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2020 | 7847 | 0.050 |
Why?
|
Chemokines, CC | 1 | 2024 | 285 | 0.050 |
Why?
|
Cell Movement | 3 | 2022 | 5190 | 0.050 |
Why?
|
Transforming Growth Factors | 1 | 2023 | 76 | 0.050 |
Why?
|
Genetic Loci | 3 | 2020 | 2630 | 0.050 |
Why?
|
Estrogen Receptor beta | 1 | 2024 | 171 | 0.050 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2024 | 415 | 0.050 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2023 | 192 | 0.050 |
Why?
|
Fluorenes | 1 | 2023 | 160 | 0.050 |
Why?
|
Oxidative Phosphorylation | 1 | 2023 | 502 | 0.050 |
Why?
|
DDT | 1 | 2021 | 32 | 0.050 |
Why?
|
Incidence | 4 | 2024 | 21513 | 0.050 |
Why?
|
Mice, Inbred BALB C | 2 | 2021 | 6209 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11858 | 0.050 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2021 | 76 | 0.050 |
Why?
|
Ubiquitins | 1 | 2023 | 365 | 0.050 |
Why?
|
Respiration Disorders | 1 | 2024 | 364 | 0.050 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group C | 1 | 2020 | 17 | 0.050 |
Why?
|
Particle Size | 2 | 2015 | 1630 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2015 | 10380 | 0.040 |
Why?
|
YY1 Transcription Factor | 1 | 2020 | 60 | 0.040 |
Why?
|
DNA-Binding Proteins | 2 | 2014 | 9600 | 0.040 |
Why?
|
Immune Evasion | 1 | 2024 | 376 | 0.040 |
Why?
|
Regression Analysis | 2 | 2021 | 6321 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2024 | 2897 | 0.040 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2021 | 355 | 0.040 |
Why?
|
Neoplasm Metastasis | 3 | 2016 | 4882 | 0.040 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2023 | 455 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8721 | 0.040 |
Why?
|
Transcriptional Elongation Factors | 1 | 2021 | 169 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2020 | 205 | 0.040 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2020 | 207 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2023 | 2838 | 0.040 |
Why?
|
Databases, Nucleic Acid | 1 | 2020 | 203 | 0.040 |
Why?
|
HT29 Cells | 1 | 2019 | 187 | 0.040 |
Why?
|
Computer Simulation | 3 | 2018 | 6251 | 0.040 |
Why?
|
Computers | 1 | 2021 | 588 | 0.040 |
Why?
|
Platelet Function Tests | 1 | 2020 | 276 | 0.040 |
Why?
|
Lipoproteins, LDL | 1 | 2022 | 643 | 0.040 |
Why?
|
Respiratory Tract Diseases | 1 | 2024 | 744 | 0.040 |
Why?
|
Drug Therapy | 1 | 2022 | 504 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2020 | 472 | 0.040 |
Why?
|
Nasopharynx | 1 | 2021 | 419 | 0.040 |
Why?
|
Response Elements | 1 | 2019 | 307 | 0.040 |
Why?
|
Nucleosomes | 1 | 2022 | 492 | 0.040 |
Why?
|
Malnutrition | 1 | 2024 | 629 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2021 | 677 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2024 | 18292 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2018 | 3796 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2023 | 1103 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2020 | 855 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 784 | 0.040 |
Why?
|
Models, Genetic | 2 | 2018 | 3447 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 613 | 0.040 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2020 | 392 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2022 | 676 | 0.040 |
Why?
|
Preoperative Period | 1 | 2019 | 565 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2023 | 1459 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2023 | 871 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2020 | 1524 | 0.030 |
Why?
|
RNA Stability | 1 | 2018 | 319 | 0.030 |
Why?
|
Immunity | 1 | 2022 | 1000 | 0.030 |
Why?
|
History, 17th Century | 1 | 2016 | 108 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2020 | 991 | 0.030 |
Why?
|
Cell Communication | 1 | 2023 | 1660 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20690 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2020 | 1167 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2019 | 752 | 0.030 |
Why?
|
Lysosomes | 1 | 2021 | 932 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 8060 | 0.030 |
Why?
|
Obesity | 1 | 2018 | 13082 | 0.030 |
Why?
|
Gene Expression | 2 | 2020 | 7581 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2020 | 717 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2020 | 65194 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 1894 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2016 | 322 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 21069 | 0.030 |
Why?
|
Th17 Cells | 1 | 2021 | 786 | 0.030 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2016 | 340 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2020 | 1743 | 0.030 |
Why?
|
Postoperative Period | 1 | 2019 | 1818 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1601 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2021 | 1404 | 0.030 |
Why?
|
Adolescent | 2 | 2020 | 88811 | 0.030 |
Why?
|
Triglycerides | 1 | 2022 | 2440 | 0.030 |
Why?
|
Biological Transport | 1 | 2018 | 2081 | 0.030 |
Why?
|
Child | 5 | 2024 | 80568 | 0.030 |
Why?
|
Plant Extracts | 1 | 2017 | 493 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2017 | 580 | 0.030 |
Why?
|
Markov Chains | 1 | 2017 | 971 | 0.030 |
Why?
|
Intraocular Pressure | 1 | 2019 | 1302 | 0.030 |
Why?
|
Cell Death | 1 | 2019 | 1676 | 0.030 |
Why?
|
Young Adult | 1 | 2020 | 59857 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1787 | 0.030 |
Why?
|
Phylogeny | 1 | 2020 | 2837 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1961 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2016 | 1695 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1463 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 1117 | 0.030 |
Why?
|
Logistic Models | 2 | 2018 | 13273 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2019 | 18962 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2018 | 967 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 2016 | 900 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 1763 | 0.020 |
Why?
|
Microsatellite Instability | 1 | 2016 | 726 | 0.020 |
Why?
|
Europe | 1 | 2019 | 3430 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2021 | 1761 | 0.020 |
Why?
|
Patient Selection | 1 | 2024 | 4248 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2017 | 1238 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13614 | 0.020 |
Why?
|
Inhalation Exposure | 1 | 2014 | 432 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1667 | 0.020 |
Why?
|
Lung | 2 | 2021 | 10046 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4782 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4111 | 0.020 |
Why?
|
Lipids | 1 | 2022 | 3317 | 0.020 |
Why?
|
DEAD-box RNA Helicases | 1 | 2013 | 386 | 0.020 |
Why?
|
Survivors | 1 | 2021 | 2373 | 0.020 |
Why?
|
Age of Onset | 1 | 2018 | 3343 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3604 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3111 | 0.020 |
Why?
|
Eating | 1 | 2017 | 1539 | 0.020 |
Why?
|
Zebrafish | 1 | 2022 | 3035 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2020 | 2688 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3542 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2879 | 0.020 |
Why?
|
Visual Acuity | 1 | 2019 | 2670 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 3498 | 0.020 |
Why?
|
DNA Repair | 1 | 2019 | 2048 | 0.020 |
Why?
|
Environment | 1 | 2015 | 1119 | 0.020 |
Why?
|
Vitamin D | 1 | 2023 | 3272 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2455 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3106 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2910 | 0.020 |
Why?
|
Gastrectomy | 1 | 2014 | 693 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2021 | 3078 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 2057 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2020 | 3690 | 0.020 |
Why?
|
Tumor Burden | 1 | 2014 | 1888 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2530 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8882 | 0.020 |
Why?
|
Haplotypes | 1 | 2014 | 2726 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9334 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2017 | 1725 | 0.020 |
Why?
|
Child, Preschool | 3 | 2016 | 42510 | 0.020 |
Why?
|
Weight Gain | 1 | 2018 | 2356 | 0.020 |
Why?
|
Comorbidity | 1 | 2022 | 10575 | 0.020 |
Why?
|
Liver | 1 | 2023 | 7559 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2016 | 4617 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3801 | 0.020 |
Why?
|
Lymphocytes | 1 | 2015 | 2601 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6838 | 0.020 |
Why?
|
Urban Population | 1 | 2015 | 2040 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5019 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10256 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2014 | 6101 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5449 | 0.020 |
Why?
|
Diet | 1 | 2024 | 8087 | 0.020 |
Why?
|
Heart Rate | 1 | 2018 | 4203 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10727 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11030 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14745 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2021 | 4863 | 0.010 |
Why?
|
Models, Statistical | 1 | 2018 | 5088 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15878 | 0.010 |
Why?
|
Software | 1 | 2017 | 4462 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10611 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 13463 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18382 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12405 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 8924 | 0.010 |
Why?
|
Blood Pressure | 1 | 2018 | 8530 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2018 | 4904 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20133 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2019 | 81537 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 40097 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 36547 | 0.010 |
Why?
|
United States | 1 | 2020 | 72909 | 0.010 |
Why?
|